The result of the study demonstrate that the EGFR-MEK1/2-ETS1 pathway is a critical positive regulator of CIP2A expression revealing a potential link between deregulated EGFR-MEK1/2-ETS1 pathway signaling and CIP2A-dependent tumor growth [87]. Here, MAP2K1 is linked to neoplasm.